Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions

Recruiting Observational Study
Invasive Fungal Infections
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
10 (estimated)
Sponsor
Peter MacCallum Cancer Centre, Australia · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This trial will demonstrate localised uptake of a radiolabelled fungal component (siderophore) in areas of known specific invasive fungal (Aspergillus) infection.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patient has provided written informed consent 2. Aged 18 years or older at written informed consent 3. Within 2 weeks of proven or probable or possible invasive fungal infection (IFI) diagnosis as per EORTC criteria 4. Imaging consistent with invasive pulmonary aspergillosis …
Contacts

Abby Douglas

03 855 96136

Abby.Douglas@petermac.org

CONTACT

Beatrice Sim

Beatrice.Sim@petermac.org

CONTACT